慢性中性粒细胞白血病分子诊断研究进展

张凤奎; 宋琳

doi:10.13201/j.issn.1004-2806.2021.11.002

慢性中性粒细胞白血病分子诊断研究进展

张凤奎^,,
宋琳

- 中国医学科学院、北京协和医学院血液病医院(中国医学科学院血液学研究所), 实验血液学国家重点实验室, 国家血液系统疾病临床医学研究中心(天津, 300020)

详细信息

通讯作者: 张凤奎,E-mail:ZhFK@Hotmail.com

中图分类号: R733.72

收稿日期: 2021-10-09

Advances in molecular diagnosis of chronic neutrophil leukemia

ZHANG Fengkui^,,
SONG Lin

More Information

Corresponding author: ZHANG Fengkui, E-mail: ZhFK@Hotmail.com

Received Date: 09 October 2021

摘要

- 慢性中性粒细胞白血病 /
- 分子诊断
- chronic neutrophil leukemia /
- molecular diagnosis

HTML全文

参考文献(27)

[1]	Maxson JE, Gotlib J, Pollyea DA, et al.Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML[J].N Engl J Med, 2013, 368(19):1781-1790.
[2]	Arber DA, Orazi A, Hasserjian R, et al.The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia[J].Blood, 2016, 127(20):2391-2405.
[3]	Dong F, van Buitenen C, Pouwels K, et al.Distinct cytoplasmic regions of the human granulocyte colony-stimulating factor receptor involved in induction of proliferation and maturation[J].Mol Cell Biol, 1993, 13(12):7774-7781.
[4]	Beekman R, Valkhof MG, Sanders MA, et al.Sequential gain of mutations in severe congenital neutropenia progressing to acute myeloid leukemia[J].Blood, 2012, 119(22):5071-5077.
[5]	Zhang H, Reister Schultz A, Luty S, et al.Characterization of the leukemogenic potential of distal cytoplasmic CSF3R truncation and missense mutations[J].Leukemia, 2017, 31(12):2752-2760.
[6]	Druhan LJ, McMahon DP, Steuerwald N, et al.Chronic neutrophilic leukemia in a child with a CSF3R T618I germ line mutation[J].Blood, 2016, 128(16):2097-2099.
[7]	Duployez N, Willekens C, Plo I, et al.Inherited transmission of the CSF3R T618I mutational hotspot in familial chronic neutrophilic leukemia[J].Blood, 2019, 134(26):2414-2416.
[8]	Fleischman AG, Maxson JE, Luty SB, et al.The CSF3R T618I mutation causes a lethal neutrophilic neoplasia in mice that is responsive to therapeutic JAK inhibition[J].Blood, 2013, 122(22):3628-3631.
[9]	Pardanani A, Lasho TL, Laborde RR, et al.CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia[J].Leukemia, 2013, 27(9):1870-1873.
[10]	Uppal G, Gong J.Chronic neutrophilic leukaemia[J].J Clin Pathol, 2015, 68(9):680-684.
[11]	Ito T, Kojima H, Otani K, et al.Chronic neutrophilic leukemia associated with monoclonal gammopathy of undetermined significance[J].Acta Haematol, 1996, 95(2):140-143.
[12]	Bain BJ, Ahmad S.Chronic neutrophilic leukaemia and plasma cell-related neutrophilic leukaemoid reactions[J].Br J Haematol, 2015, 171(3):400-410.
[13]	Usami N, Uchiyama M, Kawaguchi K, et al.Granulocyte colony-stimulating factor-producing malignant pleural mesothelioma[J].J Thorac Oncol, 2007, 2(3):257-258.
[14]	Lou E, Goodwin J, Howell DN, et al.A G-CSF-secreting adrenal carcinoma with rhabdoid-like differentiation causing leukocytosis[J].Nat Rev Urol, 2009, 6(7):392-397.
[15]	Maxson JE, Luty SB, MacManiman JD, et al.Ligand independence of the T618I mutation in the colony-stimulating factor 3 receptor(CSF3R) protein results from loss of O-linked glycosylation and increased receptor dimerization[J].J Biol Chem, 2014, 289(9):5820-5827.
[16]	Hörtner M, Nielsch U, Mayr LM, et al.Suppressor of cytokine signaling-3 is recruited to the activated granulocyte-colony stimulating factor receptor and modulates its signal transduction[J].J Immunol, 2002, 169(3):1219-1227.
[17]	Aarts LH, Roovers O, Ward AC, et al.Receptor activation and 2 distinct COOH-terminal motifs control G-CSF receptor distribution and internalization kinetics[J].Blood, 2004, 103(2):571-579.
[18]	Dong F, Qiu Y, Yi T, et al.The carboxyl terminus of the granulocyte colony-stimulating factor receptor, truncated in patients with severe congenital neutropenia/acute myeloid leukemia, is required for SH2-containing phosphatase-1 suppression of Stat activation[J].J Immunol, 2001, 167(11):6447-6452.
[19]	Szuber N, Tefferi A.Current Management of Chronic Neutrophilic Leukemia[J].Curr Treat Options Oncol, 2021, 22(7):59.
[20]	Rohrabaugh S, Kesarwani M, Kincaid Z, et al.Enhanced MAPK signaling is essential for CSF3R-induced leukemia[J].Leukemia, 2017, 31(8):1770-1778.
[21]	Szuber N, Finke CM, Lasho TL, et al.CSF3R-mutated chronic neutrophilic leukemia:long-term outcome in 19 consecutive patients and risk model for survival[J].Blood Cancer J, 2018, 8(2):21.
[22]	Zhang H, Wilmot B, Bottomly D, et al.Genomic landscape of neutrophilic leukemias of ambiguous diagnosis[J].Blood, 2019, 134(11):867-879.
[23]	Ouyang Y, Qiao C, Chen Y, et al.Clinical significance of CSF3R, SRSF2 and SETBP1 mutations in chronic neutrophilic leukemia and chronic myelomonocytic leukemia[J].Oncotarget, 2017, 8(13):20834-20841.
[24]	Meggendorfer M, Haferlach T, Alpermann T, et al.Specific molecular mutation patterns delineate chronic neutrophilic leukemia, atypical chronic myeloid leukemia, and chronic myelomonocytic leukemia[J].Haematologica, 2014, 99(12):e244-e246.
[25]	Langabeer SE, Haslam K, Kelly J, et al.Targeted next-generation sequencing identifies clinically relevant mutations in patients with chronic neutrophilic leukemia at diagnosis and blast crisis[J].Clin Transl Oncol, 2018, 20(3):420-423.
[26]	Elliott MA, Pardanani A, Hanson CA, et al.ASXL1 mutations are frequent and prognostically detrimental in CSF3R-mutated chronic neutrophilic leukemia[J].Am J Hematol, 2015, 90(7):653-656.
[27]	Zhang H, Wilmot B, Bottomly D, et al.Genomic landscape of neutrophilic leukemias of ambiguous diagnosis[J].Blood, 2019, 134(11):867-879.